Venturi Wealth Management, LLC Galapagos Nv Transaction History

Venturi Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$96.85 - $148.25 $150,020 - $229,639	-1,549 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$122.47 - $213.56 $29,025 - $50,613	237 Added 18.06%	1,549 $220,000
Q2 2020 Aug 05, 2020	BUY	$185.52 - $231.25 $242,103 - $301,781	1,305 Added 18642.86%	1,312 $259,000
Q3 2019 Oct 29, 2019	BUY	$130.44 - $187.64 $913 - $1,313	7 New	7 $1,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.81B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Venturi Wealth Management, LLC with notifications on news.